03:30 AM EDT, 09/16/2024 (MT Newswires) -- Merdad Parsey, Chief Medical Officer, on September 12, 2024, sold 21,246 shares in Gilead Sciences ( GILD ) for $1,795,287. Following the Form 4 filing with the SEC, Parsey has control over a total of 102,189 shares of the company, with 102,189 shares held directly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/882095/000112760224023946/xslF345X05/form4.xml
Price: 82.47, Change: -0.34, Percent Change: -0.41